<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>postbiotic therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/postbiotic-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 10:06:58 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>postbiotic therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Postbiotic ReFerm® Shows Promise in Advanced Liver Disease</title>
		<link>https://bioengineer.org/postbiotic-referm-shows-promise-in-advanced-liver-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 03 Jul 2025 00:25:31 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[advanced alcohol-related liver disease]]></category>
		<category><![CDATA[gut-liver axis]]></category>
		<category><![CDATA[microbiome-derived metabolites]]></category>
		<category><![CDATA[postbiotic therapy]]></category>
		<category><![CDATA[randomized controlled trial]]></category>
		<guid isPermaLink="false">https://bioengineer.org/postbiotic-referm-shows-promise-in-advanced-liver-disease/</guid>

					<description><![CDATA[In recent years, the medical community has increasingly turned its focus toward novel interventions aimed at mitigating the complex sequelae of chronic liver diseases, particularly those driven by excessive alcohol consumption. Advanced alcohol-related liver disease (ARLD) continues to account for a substantial proportion of liver failure cases globally, imposing a considerable burden on healthcare systems [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">251249</post-id>	</item>
	</channel>
</rss>
